Aveeno Baby

Product NDC: 58232-1405
11-digit product format: 582321405
Labeler code: 58232
Product ID: 58232-1405_65a13874-4e8f-4c35-96ce-5a1d0b3454d7
Type: HUMAN OTC DRUG
Nonproprietary name: Oatmeal
Dosage form: CREAM
Route: TOPICAL
Labeler: Johnson & Johnson Consumer Inc.
Application: part347
Marketing category: OTC MONOGRAPH FINAL
Marketing start: 2010-08-18
Marketing end: 0000-00-00
Substance: OATMEAL
Active strength: 10 mg/g
NDC exclude flag: No
Listing certified through: 2020-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	58232-1405		D	Discontinued by firm		2026-10-16
excluded package	package	58232-1405	58232-1405-9	D	Discontinued by firm		2026-10-16

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	58232-1405-9	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	58232-1405-9	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	58232-1405-9	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	58232-1405-9	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	58232-1405-9	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	58232-1405-9	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	58232-1405-9	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	58232-1405-9	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	58232-1405-9	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	58232-1405-9	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	58232-1405-9	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	58232-1405-9	`557ba5c1ecfa…`	`9c80585c8c6e…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Oatmeal	ACTIVE INGREDIENT	8PI54V663Y	AVEENO BABY ECZEMA THERAPY (OATMEAL) CREAM [JOHNSON & JOHNSON CONSUMER PRODUCTS COMPANY, DIVISION OF JOHNSON & JOHNSON CONSUMER COMPANIES, INC.]	1
Oatmeal	ACTIVE MOIETY	8PI54V663Y	AVEENO BABY ECZEMA THERAPY (OATMEAL) CREAM [JOHNSON & JOHNSON CONSUMER PRODUCTS COMPANY, DIVISION OF JOHNSON & JOHNSON CONSUMER COMPANIES, INC.]	1
Avena Sativa Flowering Top	INACTIVE INGREDIENT	MA9CQJ3F7F	AVEENO BABY ECZEMA THERAPY (OATMEAL) CREAM [JOHNSON & JOHNSON CONSUMER PRODUCTS COMPANY, DIVISION OF JOHNSON & JOHNSON CONSUMER COMPANIES, INC.]	1
Benzalkonium Chloride	INACTIVE INGREDIENT	F5UM2KM3W7	AVEENO BABY ECZEMA THERAPY (OATMEAL) CREAM [JOHNSON & JOHNSON CONSUMER PRODUCTS COMPANY, DIVISION OF JOHNSON & JOHNSON CONSUMER COMPANIES, INC.]	1
Cetyl Alcohol	INACTIVE INGREDIENT	936JST6JCN	AVEENO BABY ECZEMA THERAPY (OATMEAL) CREAM [JOHNSON & JOHNSON CONSUMER PRODUCTS COMPANY, DIVISION OF JOHNSON & JOHNSON CONSUMER COMPANIES, INC.]	1
Dimethicone	INACTIVE INGREDIENT	92RU3N3Y1O	AVEENO BABY ECZEMA THERAPY (OATMEAL) CREAM [JOHNSON & JOHNSON CONSUMER PRODUCTS COMPANY, DIVISION OF JOHNSON & JOHNSON CONSUMER COMPANIES, INC.]	1
Distearyldimonium Chloride	INACTIVE INGREDIENT	OM9573ZX3X	AVEENO BABY ECZEMA THERAPY (OATMEAL) CREAM [JOHNSON & JOHNSON CONSUMER PRODUCTS COMPANY, DIVISION OF JOHNSON & JOHNSON CONSUMER COMPANIES, INC.]	1
Glycerin	INACTIVE INGREDIENT	PDC6A3C0OX	AVEENO BABY ECZEMA THERAPY (OATMEAL) CREAM [JOHNSON & JOHNSON CONSUMER PRODUCTS COMPANY, DIVISION OF JOHNSON & JOHNSON CONSUMER COMPANIES, INC.]	1
Isopropyl Palmitate	INACTIVE INGREDIENT	8CRQ2TH63M	AVEENO BABY ECZEMA THERAPY (OATMEAL) CREAM [JOHNSON & JOHNSON CONSUMER PRODUCTS COMPANY, DIVISION OF JOHNSON & JOHNSON CONSUMER COMPANIES, INC.]	1
Nifurpipone	INACTIVE INGREDIENT	G7274CK635	AVEENO BABY ECZEMA THERAPY (OATMEAL) CREAM [JOHNSON & JOHNSON CONSUMER PRODUCTS COMPANY, DIVISION OF JOHNSON & JOHNSON CONSUMER COMPANIES, INC.]	1
Panthenol	INACTIVE INGREDIENT	WV9CM0O67Z	AVEENO BABY ECZEMA THERAPY (OATMEAL) CREAM [JOHNSON & JOHNSON CONSUMER PRODUCTS COMPANY, DIVISION OF JOHNSON & JOHNSON CONSUMER COMPANIES, INC.]	1
Petrolatum	INACTIVE INGREDIENT	4T6H12BN9U	AVEENO BABY ECZEMA THERAPY (OATMEAL) CREAM [JOHNSON & JOHNSON CONSUMER PRODUCTS COMPANY, DIVISION OF JOHNSON & JOHNSON CONSUMER COMPANIES, INC.]	1
Sodium Chloride	INACTIVE INGREDIENT	451W47IQ8X	AVEENO BABY ECZEMA THERAPY (OATMEAL) CREAM [JOHNSON & JOHNSON CONSUMER PRODUCTS COMPANY, DIVISION OF JOHNSON & JOHNSON CONSUMER COMPANIES, INC.]	1
Steareth-20	INACTIVE INGREDIENT	L0Q8IK9E08	AVEENO BABY ECZEMA THERAPY (OATMEAL) CREAM [JOHNSON & JOHNSON CONSUMER PRODUCTS COMPANY, DIVISION OF JOHNSON & JOHNSON CONSUMER COMPANIES, INC.]	1
Water	INACTIVE INGREDIENT	059QF0KO0R	AVEENO BABY ECZEMA THERAPY (OATMEAL) CREAM [JOHNSON & JOHNSON CONSUMER PRODUCTS COMPANY, DIVISION OF JOHNSON & JOHNSON CONSUMER COMPANIES, INC.]	1

UNII, Preferred term, Matched term table
UNII	Preferred term	Matched term
8PI54V663Y	OATMEAL	OATMEAL

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Aveeno Baby Cleansing and Eczema Therapy	Johnson & Johnson Consumer Inc.	2018-12-18	HUMAN OTC DRUG LABEL	3

Aveeno Baby

NDC auxiliary status#

Observed NDC auxiliary status history#

Reported adverse events (FAERS/openFDA)#

DailyMed Socrata Ingredients#

Related Records#

Related UNII Ingredients#

Related DailyMed Labels#